Grand Rounds

Symptom Management Strategies for Patients Receiving Anaplastic Lymphoma Kinase Inhibitors for Non–Small Cell Lung Cancer

Jennifer Jacky, MSN, ARNP, and Christina Baik, MD, MPH

Seattle Cancer Care Alliance and Department of Medicine (Medical Oncology Division), University of Washington, Seattle, Washington; and Department of Medicine (Medical Oncology Division), University of Washington School of Medicine, Seattle, Washington

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

Jennifer Jacky, MSN, ARNP, Seattle Cancer Care Alliance, Thoracic Head and Neck Medical Oncology, 825 Eastlake Avenue East, Seattle, WA 98109. E-mail: Jjacky@seattlecca.org


J Adv Pract Oncol 2017;8:729–735 | https://doi.org/10.6004/jadpro.2017.8.7.6 | © 2017 Harborside™


  



For access to the full length article, please sign in.

Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
ADVERTISEMENT
Section Seperator
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.